Dr. Laura Niklason, a world leader in tissue engineering and cellular therapies, founded Humacyte in 2004. Laura has been deeply involved in all key aspects of Humacytes growth, including scientific
Dr. Laura Niklason, a world leader in tissue engineering and cellular therapies, founded Humacyte in 2004. Laura has been deeply involved in all key aspects of Humacytes growth, including scientific
A driving force in the growth of Williams-Sonoma, Inc., Laura Alber joined the company in 1995 and has served as president and chief executive officer, as well as a member
A driving force in the growth of Williams-Sonoma, Inc., Laura Alber joined the company in 1995 and has served as president and chief executive officer, as well as a member
As President and CEO of Jackson, Laura Prieskorn executes their mission of helping more Americans approaching retirement achieve financial freedom for life by ensuring Jackson associates and resources are aligned
As President and CEO of Jackson, Laura Prieskorn executes their mission of helping more Americans approaching retirement achieve financial freedom for life by ensuring Jackson associates and resources are aligned
Laurel M. Hurd is President, CEO and director of Interface, Inc., since April 18, 2022. She has been Segment President of the Learning & Development Segment at Newell Brands Inc.
Laurel M. Hurd is President, CEO and director of Interface, Inc., since April 18, 2022. She has been Segment President of the Learning & Development Segment at Newell Brands Inc.
Kristin Yarema, Ph.D., is the CEO of Poseida Therapeutics, Inc., a biopharmaceutical company dedicated to developing innovative therapies for cancer and genetic diseases. Dr. Yaremas leadership is characterized by a
Kristin Yarema, Ph.D., is the CEO of Poseida Therapeutics, Inc., a biopharmaceutical company dedicated to developing innovative therapies for cancer and genetic diseases. Dr. Yaremas leadership is characterized by a
Lara S. Sullivan, M.D., is the CEO of Pyxis Oncology, Inc., a biopharmaceutical company focused on developing innovative therapies for oncology. Dr. Sullivans leadership is defined by her dedication to
Lara S. Sullivan, M.D., is the CEO of Pyxis Oncology, Inc., a biopharmaceutical company focused on developing innovative therapies for oncology. Dr. Sullivans leadership is defined by her dedication to
Laura A. Francis has served as Chief Executive Officer and a Director on SI-Bones Board since April 2021. In previous positions as chiy public in October 2018 and building the
Laura A. Francis has served as Chief Executive Officer and a Director on SI-Bones Board since April 2021. In previous positions as chiy public in October 2018 and building the
Kim Scott is the CEO of Kinder Morgan, Inc., one of the largest energy infrastructure companies in North America, specializing in the transportation and storage of natural gas, crude oil,
Kim Scott is the CEO of Kinder Morgan, Inc., one of the largest energy infrastructure companies in North America, specializing in the transportation and storage of natural gas, crude oil,
Kimberly Blackwell, M.D., is the CEO of Zentalis Pharmaceuticals, Inc., a biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. Dr. Blackwells leadership is marked by her commitment to
Kimberly Blackwell, M.D., is the CEO of Zentalis Pharmaceuticals, Inc., a biopharmaceutical company dedicated to developing innovative therapies for cancer treatment. Dr. Blackwells leadership is marked by her commitment to
Kimberly K. Ryan serves as the CEO, President and Director of Hillenbrand, Inc. She previously held the role of Executive Vice President at Hillenbrand, Inc. since 2021 until 2021. She
Kimberly K. Ryan serves as the CEO, President and Director of Hillenbrand, Inc. She previously held the role of Executive Vice President at Hillenbrand, Inc. since 2021 until 2021. She